organs used in the body of human
devices will have higher clinical trial requirements, and the R&D cycle will be longer than that of in vitro reagents or devices). From the balance of R&D risk and unprofitability, we can focus on Class III medical device R&D and manufacturing enterprises with core technology and leading advantages.
2, the current industry development is relatively backward, resulting in more room for growth.
3, the number of medical device companies, small scale, low-end products fierce competition.
4, medical devices in the consumables with the concept of consumer goods, the future growth is widely favored. Price
There is a strong ability to transfer on the ability to resolve the risk of rising raw material prices.
5, "Twelfth Five-Year" period will strongly support the development of domestic medical equipment, the implementation of centralized bidding and procurement,
priority procurement of domestic medical equipment.
6, high-end devices and large medical equipment import substitution trend is obvious, but sales are particularly complex
7, for medical diagnostic equipment companies focus on product technology sustainability, cost-effective and marketing capabilities;
competition or management and marketing.